Connect with us
Colombia’s therapeutic cannabis industry grew 25–35% last year, driven by regulatory stability, medical acceptance, and rising prescriptions. Nearly 25% of Colombians have used medicinal or cosmetic...
Spain’s medicines agency AEMPS has launched the registration process for standardized medicinal cannabis preparations. Pharmaceutical laboratories must apply electronically under the October 7 royal decree, which...
In 2025, Colombia’s medical cannabis industry grew 25%–35%, driven by regulatory stability, expanding exports, and increased medical adoption. Pharmaceutical products led demand, oils dominated sales, and...
A December 2025 US executive order signals a major policy shift by treating medical cannabis as a public health issue rather than a tolerated exception. It...
In 2025 Poland, legal medical cannabis has clear quality, safety, and dosing advantages over unpredictable illegal street product, making therapeutic use more sensible than recreational smoking....
In 2025, medical cannabis use in Poland stabilized and matured. Pharmacies dispensed over 5 tons to 105,000 patients through 537,000 prescriptions. Growth slowed after rapid expansion...
A new US appropriations bill effectively redefining hemp tightens THC limits, bans synthetic cannabinoids, and could dismantle much of the current hemp-derived products market. Critics call...
The International Congress on Industrial Hemp and Medicinal Cannabis gathered over 1,500 participants from diverse sectors in Argentina. Led by Drs. Kochen and Morante, it featured...
Medical cannabis in Colombia is gaining traction, with 21% open to its use. Strict regulations require prescriptions and INVIMA certification for quality assurance. Patients can access...
Poland now requires in-person doctor visits for medical cannabis prescriptions, replacing online approvals. This change, effective November 7th, 2024, enhances patient safety but reduces prescription numbers....